Impact on liver position under breath-hold by computed tomography contrast agents in stereotactic body radiotherapy of liver cancer
Abstract
Background: We investigated variations in liver position relative to the vertebral bone for liver cancer treated with stereotactic body radiation therapy under expiratory phase breath-hold (BH) for treatment with contrast-enhanced-computed tomography (CECT), non-CECT, and cone-beam computed tomography (CBCT).
Materials and methods: Seventeen consecutive patients using a contrast enhancement (CE) agent for the CT simulation session for this retrospective study were selected. The first computed tomography (CT) scan without the use of CE agent in the expiratory phase was used for treatment planning (pCT). The remaining three CT scans without a CE agent under expiratory phase BH were acquired successively without repositioning to evaluate the intra-fraction variation in liver position. Furthermore, a three-phase CT scan (arterial, portal, and late phases) accompanied by a CE agent under expiratory phase BH was acquired for target delineation. CBCT scans without the use of a CE agent under expiratory phase BH were acquired for treatment. Inter-fractional variations (non-CECT or CECT) in liver position were measured using the difference between CBCT and pCT or each 3 phase CECT images, respectively.
Results: The average ± standard deviations for intrafractional, non-CECT interfractional variations, and CECT interfractional variations were 1.0 ± 1.3, 2.5 ± 2.6, and 6.4 ± 6.4 mm, respectively, in the craniocaudal (CC) direction. Intra- and inter-fractional variations in liver position were relatively small for non-CECT. However, significant inter-fractional liver position variations in CECT were observed in the expiratory phase BH. The position of the liver should be carefully considered when applying CECT images for image-guided radiotherapy.
Keywords: image-guided radiotherapycontrast enhancement agentstereotactic body radiotherapyliver cancer radiotherapyintra-fraction liver positioninter-fraction liver position
References
- Davies SC, Hill AL, Holmes RB, et al. Ultrasound quantitation of respiratory organ motion in the upper abdomen. Br J Radiol. 1994; 67(803): 1096–1102.
- Balter JM, Dawson LA, Kazanjian S, et al. Determination of ventilatory liver movement via radiographic evaluation of diaphragm position. Int J Radiat Oncol Biol Phys. 2001; 51(1): 267–270.
- Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys. 2006; 33(10): 3874–3900.
- Kimura T, Hirokawa Y, Murakami Y, et al. Reproducibility of organ position using voluntary breath-hold method with spirometer for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 60(4): 1307–1313.
- Eccles C, Brock KK, Bissonnette JP, et al. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006; 64(3): 751–759.
- Dawson LA, Brock KK, Kazanjian S, et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys. 2001; 51(5): 1410–1421.
- Beddar AS, Kainz K, Briere TM, et al. Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT. Int J Radiat Oncol Biol Phys. 2007; 67(2): 630–638.
- Yang J, Cai J, Wang H, et al. Is diaphragm motion a good surrogate for liver tumor motion? Int J Radiat Oncol Biol Phys. 2014; 90(4): 952–958.
- Lu L, Diaconu C, Djemil T, et al. Intra- and inter-fractional liver and lung tumor motions treated with SBRT under active breathing control. J Appl Clin Med Phys. 2018; 19(1): 39–45.
- Lu L, Ouyang Zi, Lin S, et al. Dosimetric assessment of patient-specific breath-hold reproducibility on liver motion for SBRT planning. J Appl Clin Med Phys. 2020; 21(7): 77–83.
- Park JC, Park SHo, Kim JH, et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys. 2012; 39(10): 6431–6442.
- Kawahara D, Ozawa S, Nakashima T, et al. Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer. Rep Pract Oncol Radiother. 2018; 23(2): 84–90.
- Guckenberger M, Sweeney RA, Wilbert J, et al. Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2008; 71(1): 297–304.
- Case RB, Sonke JJ, Moseley DJ, et al. Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009; 75(1): 302–308.
- Hawkins MA, Brock KK, Eccles C, et al. Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy. Int J Radiat Oncol Biol Phys. 2006; 66(2): 610–619.
- Zhong R, Wang J, Jiang X, et al. Hypofraction radiotherapy of liver tumor using cone beam computed tomography guidance combined with active breath control by long breath-holding. Radiother Oncol. 2012; 104(3): 379–385.
- Choi GW, Suh Y, Das P, et al. Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration-based image guidance. Radiat Oncol. 2019; 14(1): 154.
- Onishi H, Kawakami H, Marino K, et al. A simple respiratory indicator for irradiation during voluntary breath holding: a one-touch device without electronic materials. Radiology. 2010; 255(3): 917–923.
- Tarohda TI, Ishiguro M, Hasegawa K, et al. The management of tumor motions in the stereotactic irradiation to lung cancer under the use of Abches to control active breathing. Med Phys. 2011; 38(7): 4141–4146.
- Miura H, Ozawa S, Nakao M, et al. Evaluation of interbreath-hold lung tumor position reproducibility with vector volume histogram using the breath-hold technique. Med Dosim. 2020; 45(3): 252–255.
- Fuss M, Shi C, Papanikolaou N. Tomotherapeutic stereotactic body radiation therapy: Techniques and comparison between modalities. Acta Oncol. 2006; 45(7): 953–960.
- Kobayashi D, Takahashi O, Ueda T, et al. Risk factors for adverse reactions from contrast agents for computed tomography. BMC Med Inform Decis Mak. 2013; 13: 18.
- Bertholet J, Worm E, Høyer M, et al. Cone beam CT-based set-up strategies with and without rotational correction for stereotactic body radiation therapy in the liver. Acta Oncol. 2017; 56(6): 860–866.
- Wunderink W, Méndez Romero A, Seppenwoolde Y, et al. Potentials and limitations of guiding liver stereotactic body radiation therapy set-up on liver-implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2010; 77(5): 1573–1583.
- Cao M, Lasley FD, Das IJ, et al. Evaluation of rotational errors in treatment setup of stereotactic body radiation therapy of liver cancer. Int J Radiat Oncol Biol Phys. 2012; 84(3): e435–e440.
- Yue J, Sun X, Cai J, et al. Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor. Int J Radiat Oncol Biol Phys. 2012; 82(2): 834–841.
- Xu Q, Hanna G, Grimm J, et al. Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2014; 90(1): 94–101.
- Brock KK, Hawkins M, Eccles C, et al. Improving image-guided target localization through deformable registration. Acta Oncol. 2008; 47(7): 1279–1285.
- Eccles CL, Tse RV, Hawkins MA, et al. Intravenous contrast-enhanced cone beam computed tomography (IVCBCT) of intrahepatic tumors and vessels. Adv Radiat Oncol. 2016; 1(1): 43–50.
- Rankine AW, Lanzon PJ, Spry NA. Effect of contrast media on megavoltage photon beam dosimetry. Med Dosim. 2008; 33(3): 169–174.